Individualized Out-of-Pocket Price Estimators for "Shoppable" Surgical Procedures: A Nationwide Cross-Sectional Study of US Hospitals
- PMID: 36936723
- PMCID: PMC10013173
- DOI: 10.1097/AS9.0000000000000162
Individualized Out-of-Pocket Price Estimators for "Shoppable" Surgical Procedures: A Nationwide Cross-Sectional Study of US Hospitals
Abstract
To estimate the nationwide prevalence of individualized out-of-pocket (OOP) price estimators at US hospitals, characterize patterns of inclusion of 14 specified "shoppable" surgical procedures, and determine hospital-level characteristics associated with estimators that include surgical procedures.
Background: Price transparency for shoppable surgical services is a key requirement of several recent federal policies, yet the extent to which hospitals provide online OOP price estimators remains unknown.
Methods: We reviewed a stratified random sample of 485 U.S. hospitals for the presence of a tool to allow patients to estimate individualized OOP expenses for healthcare services. We compared characteristics of hospitals that did and did not offer online price estimators and performed multivariable modeling to identify facility-level predictors of hospitals offering price estimator with and without surgical procedures.
Results: Nearly two-thirds (66.0%) of hospitals in the final sample (95% confidence interval 61.6%-70.1%) offered an online tool for estimating OOP healthcare expenses. Approximately 58.5% of hospitals included at least one shoppable surgical procedure while around 6.6% of hospitals included all 14 surgical procedures. The most common price reported was laparoscopic cholecystectomy (55.1%), and the least common was recurrent cataract removal (20.0%). Inclusion of surgical procedures varied by total annual surgical volume and health system membership. Only 26.9% of estimators explicitly included professional fees.
Conclusions: Our findings highlight an ongoing progress in price transparency, as well as key areas for improvement in future policies to help patients make more financially informed decisions about their surgical care.
Keywords: financial toxicity; health care costs; health spending; out of pocket costs.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
Similar articles
-
Evaluating hospital consumer-friendly price-estimator tools for shoppable services within dermatology.Arch Dermatol Res. 2023 Aug;315(6):1813-1821. doi: 10.1007/s00403-023-02527-3. Epub 2023 Jan 27. Arch Dermatol Res. 2023. PMID: 36705758
-
Not Clearing the Air: Hospital Price Transparency for a Laparoscopic Cholecystectomy.J Surg Res. 2022 Dec;280:501-509. doi: 10.1016/j.jss.2022.07.037. Epub 2022 Sep 5. J Surg Res. 2022. PMID: 36081309
-
The Increasing Financial Burden of Outpatient Elective Surgery for the Privately Insured.Ann Surg. 2020 Sep 1;272(3):530-536. doi: 10.1097/SLA.0000000000004201. Ann Surg. 2020. PMID: 32740255 Free PMC article.
-
The impact of price transparency on consumers and providers: A scoping review.Health Policy. 2020 Aug;124(8):819-825. doi: 10.1016/j.healthpol.2020.06.001. Epub 2020 Jun 5. Health Policy. 2020. PMID: 32576391
-
Healthcare price transparency in North America and Europe.Br J Radiol. 2023 Nov;96(1151):20230236. doi: 10.1259/bjr.20230236. Epub 2023 Sep 3. Br J Radiol. 2023. PMID: 37660401 Free PMC article. Review.
Cited by
-
Catastrophic health expenditures, insurance churn, and non-employment among women with breast cancer.JNCI Cancer Spectr. 2024 Feb 29;8(2):pkae006. doi: 10.1093/jncics/pkae006. JNCI Cancer Spectr. 2024. PMID: 38331405 Free PMC article.
-
Rates of price disclosure associated with the surgical treatment of early-stage breast cancer one year after implementation of federal regulations.Breast Cancer Res Treat. 2024 Jan;203(2):397-406. doi: 10.1007/s10549-023-07160-2. Epub 2023 Oct 18. Breast Cancer Res Treat. 2024. PMID: 37851289
References
Grants and funding
LinkOut - more resources
Full Text Sources